Olezarsen, Acute Pancreatitis, and Familial Chylomicronemia Syndrome.
Erik S G StroesVeronica J AlexanderEwa Karwatowska-ProkopczukRobert A HegeleMarcello ArcaChristie M BallantyneHandrean SoranThomas A ProhaskaShuting XiaHenry N GinsbergJoseph L WitztumSotirios Tsimikasnull nullPublished in: The New England journal of medicine (2024)
In patients with familial chylomicronemia syndrome, olezarsen may represent a new therapy to reduce plasma triglyceride levels. (Funded by Ionis Pharmaceuticals; Balance ClinicalTrials.gov number, NCT04568434.).